PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis

It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivat...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Endocrinol (Lausanne)
Main Authors: Vella, Veronica, Nicolosi, Maria Luisa, Giuliano, Stefania, Bellomo, Maria, Belfiore, Antonino, Malaguarnera, Roberta
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2017
נושאים:
Endocrinology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319972/
https://ncbi.nlm.nih.gov/pubmed/28275367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00031
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים